PAUL HRISO: Open Payments
NPI 1295754158 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 77 payments from 15 companies in 2025. Trend: 2023 $1,314 · 2024 $1,361 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $445 |
| Axsome Therapeutics, Inc. | 16 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $169 |
| Tris Pharma Inc | 6 | $100 |
| Lundbeck LLC | 5 | $79 |
| Bausch Health US, LLC | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Almatica Pharma LLC | 2 | $37 |
Products named: VRAYLAR, CAPLYTA, Auvelity, Sunosi, Dyanavel XR, REXULTI, APLENZIN, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
